The Official Journal of EuroPCR and the European Association of Percutaneous Coronary Interventions (EAPCI)

Clinical research

The ability of high dose rosuvastatin to improve plaque composition in non-intervened coronary arteries: rationale and design of the Integrated Biomarker and Imaging Study-3 (IBIS-3)

EuroIntervention 2012;8:235-241. DOI: 10.4244/EIJV8I2A37

1. Thoraxcenter, Department of Cardiology, Erasmus Medical Center, Rotterdam, The Netherlands; 2. AstraZeneca, Wilmington, DE, USA

Aims: Acute coronary syndromes (ACS) are often caused by rupture of non-flow limiting “vulnerable” atherosclerotic plaque, characterised by a la

Sign in to read and download the full article

Forgot your password?
No account yet? Sign up for free!
Create my pcr account

Join us for free and access thousands of articles from EuroIntervention, as well as presentations, videos, cases from PCRonline.com

Read next article
Adjusting a polymer formulation for an optimal bioresorbable stent: a 6-month follow-up study